H.I.G. Capital, a leading global investment firm with USD 52 bn of equity capital under management, announced that one of its affiliates has completed the acquisition of Celerion Holdings, a leading full-service provider of
Tags :Andreas Müller
VectivBio Holding, a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, has announced the pricing of a USD 125 m underwritten offering of ordinary shares. The underwritten offering consists of 16,700,000 ordinary shares at
Solenis has entered into a definitive agreement to acquire Kolb Distribution‘s paper process chemicals business, a unit of KLK Kolb Group. The deal includes a long-term supply agreement, in which the KLK Kolb Group
The Berlin-based insurtech wefox Holding has announced that it has successfully reached an agreement for its Series D funding round, increasing its post-money valuation to USD 4.5 bn. The equity round was led by Mubadala Investment
Dufry has announced that it has entered into an agreement with the Italian company Edizione to collaborate with Autogrill to create a new integrated global travel experience. The combined company will serve more than 2.3 billion
Ahlström Capital, a finnish family-owned investment company, has announced the merger of Swiss-based company Enics with GPV International, owned by Schouw & Co., to create a European electronics giant. The mergering between the two
VectivBio Holding a clinical-stage biopharmaceutical company, has announced a combined gross proceeds from public offering and private sale of USD 50 million. On one side, the company has announced the pricing of a follow-on public offering
SonarSource, a platform for clean code, has completed a growth equity financing by General Catalyst, Advent International, Insight Partners, and Permira’s Growth Opportunities Fund. The financing raised USD 412 million in new investment
Bcomp, lightweighting specialists, closed its oversubscribed Series B financing round of CHF 32.4 million (USD 35 m). The round was led by automotive OEM venture funds BMW i Ventures and included a group of mobility
VectivBio, a clinical-stage biotechnology company developing transformational medicines for patients with serious rare diseases, has entered into a loan agreement with Kreos Capital, a global growth lender to life sciences and healthcare companies, granting VectivBio
